Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 26, 2024
Distillery Therapeutics

HFE2 for blood-brain barrier integrity in MS

BioCentury | Aug 21, 2021
Targets & Mechanisms

Next-generation multiple sclerosis therapies look beyond B cells 

Early-stage approaches aim for more precise immune suppression, remyelination
BioCentury | Mar 19, 2019
Distillery Therapeutics

RGMA protein to treat peritonitis

BioCentury | Oct 31, 2017
Distillery Techniques

Disease models

BioCentury | Apr 21, 2011
Distillery Therapeutics

Indication: Inflammation

BioCentury | Mar 31, 2011
Distillery Therapeutics

Indication: Neurology

Items per page:
1 - 6 of 6